《大行報告》摩通相信碧桂園(02007.HK)流動性壓力持續
摩根大通發表報告指,碧桂園(02007.HK)日前發盈警公告,預期截至今年6月30日止中期由盈轉虧,錄得淨虧損介乎約450億元至550億元人民幣,消息並不令人意外,管理層亦承認公司正面臨嚴重流動性困難。
摩通認為,此很可能是引發大型信貸危機的前奏,碧桂園或可能正在為債務重組作準備,到目前為止仍然沒有見到內地當局發表聲明及出手提供進一步支持或救助的跡象。
該行又指,碧桂園8月至今銷售數據依然疲軟,內地月初至今20大城市銷售按年跌30%,較過去四年平均水平低出49%,因此相信碧桂園流動性壓力持續存在,給予「減持」評級,目標價0.8元,對應今明兩年平均預測市賬率0.1倍。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.